See more : ECI Technology Holdings Limited (8013.HK) Income Statement Analysis – Financial Results
Complete financial analysis of NewAge, Inc. (NBEV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NewAge, Inc., a leading company in the Beverages – Non-Alcoholic industry within the Consumer Defensive sector.
- AbCellera Biologics Inc. (ABCL) Income Statement Analysis – Financial Results
- Octava Minerals Limited (OCT.AX) Income Statement Analysis – Financial Results
- Applied Biosciences Corp. (APPB) Income Statement Analysis – Financial Results
- Naked Wines plc (MJWNY) Income Statement Analysis – Financial Results
- TLG Acquisition One Corp. (TLGA-WT) Income Statement Analysis – Financial Results
NewAge, Inc. (NBEV)
About NewAge, Inc.
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado. On August 30, 2022, NewAge, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 279.47M | 253.71M | 52.16M | 52.19M | 25.30M | 0.00 | 1.04M | 968.94K |
| Cost of Revenue | 101.98M | 101.00M | 42.87M | 39.79M | 19.51M | 0.00 | 879.46K | 684.59K |
| Gross Profit | 177.49M | 152.71M | 9.30M | 12.40M | 5.80M | 0.00 | 164.19K | 284.35K |
| Gross Profit Ratio | 63.51% | 60.19% | 17.82% | 23.76% | 22.91% | 0.00% | 15.73% | 29.35% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 113.21M | 0.00 | 20.29M | 14.61M | 7.84M | 0.00 | 1.28M | 415.09K |
| Selling & Marketing | 0.00 | 0.00 | 2.78M | 3.84M | 1.58M | 0.00 | 155.98K | 174.01K |
| SG&A | 113.21M | 0.00 | 23.07M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Other Expenses | 99.13M | 199.33M | 2.31M | 668.05M | 1.47M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 212.34M | 199.33M | 25.38M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Cost & Expenses | 314.32M | 300.33M | 68.24M | 58.24M | 28.93M | 0.00 | 2.32M | 1.27M |
| Interest Income | 0.00 | -227.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.38M | 3.90M | 1.07M | 228.04K | 299.08K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.93M | 8.76M | 2.31M | 1.61M | 523.75K | 77.82K | 169.40K | 103.21K |
| EBITDA | -29.93M | -64.50M | -17.68M | -1.70M | -2.81M | 0.00 | -1.08M | -227.14K |
| EBITDA Ratio | -10.71% | -25.42% | -33.90% | -3.26% | -11.11% | 0.00% | -103.52% | -23.44% |
| Operating Income | -34.85M | -80.00M | -19.37M | -6.05M | -3.63M | 0.00 | -1.28M | -304.75K |
| Operating Income Ratio | -12.47% | -31.53% | -37.14% | -11.59% | -14.33% | 0.00% | -122.27% | -31.45% |
| Total Other Income/Expenses | -2.60M | -98.17M | -1.69M | 2.51M | -6.32K | 0.00 | 26.32K | -25.59K |
| Income Before Tax | -37.45M | -77.17M | -21.06M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Income Before Tax Ratio | -13.40% | -30.42% | -40.38% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| Income Tax Expense | -1.90M | 12.67M | -8.93M | 2.74M | 292.76K | 0.00 | 26.32K | -25.59K |
| Net Income | -39.34M | -89.84M | -12.14M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Net Income Ratio | -14.08% | -35.41% | -23.26% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| EPS | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| EPS Diluted | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| Weighted Avg Shares Out | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
| Weighted Avg Shares Out (Dil) | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
NewAge Launches New Children's Multivitamin With Better Absorption for Immune System Support
NewAge (NBEV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
NewAge, Inc., Recognized as a Top Revenue Generating Company by DSN Global
NewAge's Lucim™ Skin Care Brand Recognized by Good Face Project for Exceptional Quality and Safety
NewAge, Inc. (NBEV) CEO Brent Willis on Q4 2020 Results - Earnings Call Transcript
NBEV Stock Price Increases Over 9% Pre-Market: Why It Happened
NewAge Announces Timing for Fourth Quarter and Full Year 2020 Financial Results and Conference Call
4 Cannabis Stocks in the News This Week
NewAge Announces Evolution of Management Team
9 Red-Hot Cannabis Stocks Blazing This Week
Source: https://incomestatements.info
Category: Stock Reports